Close

Cantor Fitzgerald Starts Paratek Pharmaceuticals (PRTK) at Buy

May 11, 2015 4:13 PM EDT Send to a Friend
Cantor Fitzgerald initiates coverage on Paratek Pharmaceuticals (NASDAQ: PRTK) with a Buy rating and a price target of $35.00.Anayst Daniel ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login